ELIZABETH GAULIN: Open Payments
NPI 1891334496 · NORTH ATTLEBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 49 payments from 11 companies in 2025. Trend: 2023 $1,404 · 2024 $2,257 · 2025 $1,064
Food & beverage: $1,037Education: $27
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $220 |
| E.R. Squibb & Sons, L.L.C. | 8 | $154 |
| Vanda Pharmaceuticals Inc. | 12 | $153 |
| Otsuka America Pharmaceutical, Inc. | 6 | $137 |
| Axsome Therapeutics, Inc. | 4 | $111 |
| Lundbeck LLC | 4 | $103 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| Alkermes, Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $48 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
Products named: REXULTI, AUSTEDO XR, COBENFY, FANAPT, Sunosi, Auvelity, VRAYLAR, ABILIFY MAINTENA.
Industry payments across MA — which companies pay providers there.
